DENVER, CO--(Marketwired - Sep 29, 2016) - Ubiquitech Software Corp. (OTC PINK: UBQU), with pending name change to HempLife Today™, is announcing a groundbreaking new development for its current line of popular CannazALL™ CBD products derived from hemp. Designed to improve its current line of CBD products and reach deeper into the multi-billion dollar natural health industry.
The NanoTech Infusion Process™
The Company has developed the new NanoTech Infusion Process™ designed to enhance the current line of CannazALL™ CBD products by adding more hemp plant terpenes, sterols, botanicals, and other absorption enhancing hemp plant materials into its CannazALL™ CBD products. This scientifically designed and tested infusion process better blends the CBD (Cannabidiol), and the additional beneficial plant materials, to create a richer "full spectrum" entourage effect and benefit.
Creates a richer more full spectrum CBD product
The NanoTech Infusion Process™ has been developed over several months and allows for the precise blending and suspension of the additional hemp plant materials into the Company's purpose grown CBD. Creating a richer more full bodied CBD product. In testing this new process, the Company found that test subjects who ingested the new plant extracts alone said they could "feel the difference" and reported positive effects and an overall more calming experience. When added to the current CannazALL™ CBD formulas this process will make CannazALL™ the most unique CBD products available.
Even though CannazAll™ CBD products already contain industry leading hemp plant extracts, the Company tests have shown that the extra hemp plant materials from the NanoTech Infusion Process™ provide more health benefits without changing the CBD formulas, concentrates, or potencies, of its products in any way.
"This is truly an enhancement and improvement of our already industry leading CBD formulas," said Luke Dreyer, COO, "and our testing shows that this process only adds to our products' benefits, but doesn't change the actual CBD content at all because the CBD and the hemp plant extracts are two different things."
"Moving forward this is how we are going to differentiate ourselves from the competition and continue to be a forward thinking company," said James Ballas CEO. "By adding this new infusion process to our products we are taking a big step forward in the technology and science behind the benefits of hemp derived CBD products, and this will help us market our products to an ever broadening audience, helping us lead the pack throughout 2017, and beyond."
"Everything we do is designed to create the finest products we can and to increase our sales by going deeper into the marketplace and offering more and more people the CannazALL™ CBD experience," adds James Ballas.
Company looks to move deeper into the multi-billion dollar natural healing industry
Internal Company data show that enhancing the CannazALL™ CBD line will result in higher sales as this process will attract more customers interested in a more complete holistic, and natural healing aid. Giving HempLife Today™ an even bigger edge in the multi-billion dollar natural healing industry. The new NanoTech Infusion Process™ will be introduced over the next 30-60 days.
About Ubiquitech (HempLife Today™)
Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday.com™
HempLife Today™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It's popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid, all offered @ www.HempLifeToday.com
This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward- looking statements in order to reflect events or circumstances that may arise after the date of this release.